Kentucky is suing Purdue Pharma on claims that the company misrepresented its prescription painkiller, resulting in a wave of addiction and increased medical costs across the state. Kentucky officials filed theirs, which included claims that Purdue Pharma lied about the addictiveness of the drug to doctors, who then overprescribed it to an unwitting...» Read More
Crystal Peoples-Stokes, Democratic New York Assembly member, discusses the failed war on drugs and her newly introduced marijuana regulation and taxation act that would regulate marijuana like alcohol.
Having an addict in the family presents a deeply troubling dilemma. How do you help those you love, while protecting your own financial future?
CNBC's Bertha Coombs reports on the race to treat drug-resistant infections.
Ben Livingston, director of the Center for Legal Cannabis, discusses the legalization anniversary event.
A Colorado medical marijuana dispensary became the first business in the U.S. licensed to sell recreational marijuana.
An experimental GlaxoSmithKline drug, designed to fight heart disease in a new way, failed to meet its main goal in a major clinical study.
London-listed Shire has agreed to buy U.S. company ViroPharma for about $4.2 billion in cash.
The FDA proposed a new rule that would open up generic drugmakers to liability and apply some of the same regulations used for brand manufacturers.
CNBC's Tyler Mathisen, Jon Fortt and Michelle Caruso-Cabrera debate the money to be made from the legalization of marijuana.
You've heard of ED. Now there's a drug for PE, made by a 4-year-old start-up. It's designed for men to make their mates happier.
Will.i.am talks to CNBC about the "failure" of the Drug Abuse Resistance Education program and how thousands of Americans are now in prison because of lack of opportunities in their neighborhood.
The FDA is expected to decide on whether to fast track Perjeta for early treatment of breast cancer by Oct. 31.
Biogen Idec has agreed to pay another $100 million upfront to Isis Pharmaceuticals as part of a broad collaboration to develop neurological medicines.
The cannabis legalization trend is creating jobs in states where laws have been relaxed, and big business is "looking into the industry in a big way," an expert says.
A warning about stock scams involving marijuana related companies has been issued; CNBC's Mary Thompson has the story.
FINRA is issuing a new investor alert called "marijuana stock scams." CNBC's Mary Thompson offers insight.
FINRA warned Tuesday that scammers have been targeting investors attempting to tap into the growing U.S. marijuana industry.
Colorado and Washington are trying to figure out a system to regulate and track the use of legalized marijuana, reports CNBC's Jane Wells.
Doug Fine, author of 'Too High to Fail', explains the benefits to the economy that legalizing cannabis in the U.S. would have.
CNBC's Tom Mackenzie comments on the need for a globally coordinated approach to tackling the drugs trade.